ESTRELLA IMMUNOPHARMA ACTIVATES OREGON HEALTH & SCIENCE UNIVERSITY AS THIRD CLINICAL SITE FOR PHASE I/II STARLIGHT-1 TRIAL IN B-CELL NON-HODGKIN’S LYMPHOMA

Reuters · 2d ago

Please log in to view news